PAVM PAVMED INC Capital Structure Changes 8-K Filing 2025 - Stock Offering On April 17, 2025, PAVmed Inc. entered into a Sales Agreement with Maxim Group LLC to sell up to $2,880,000 of its common stock, with a 3.0% commission for the agent. The proceeds will be used for working capital and general corporate purposes.Get access to all SEC 8-K filings of the PAVMED INC